glp 1 for eating disorders The rapid rise of GLP-1 receptor agonists presents a complex dilemma clinicians managing patients with disorders. While these medications show potential in reducing binge eating behaviors by targeting brain reward Use and misuse of GLP-1
Description
doi: 10.1016/j.arr.2021.101464 [DOI] [PubMed] [Google Scholar] 74
Their efficacy in managing T2D and obesity is well-established, with GLP-1RAs promoting glycemic control, weight loss, and even reducing cardiovascular complications in T2D patients
Most GLP-1 medications all say the same thing: dose increases should be done every four weeks at the earliest
Understanding exactly how this new drug worksand why it isnt yet availableis critical for making the right decision for your health today
GI-related effects on intimacy typically resolve within the first six to eight weeks
